Clinical trials
Recruiting Phase 3 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 3 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
| BioNTech SE | 1 |
| Charles University, Czech Republic | 1 |
| Daiichi Sankyo | 1 |
| Genmab | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Hutchmed | 1 |
| Kara Romano, MD | 1 |
| Leiden University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 16 |
| Uterine Neoplasms | 4 |
| Frailty | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.